CALIGAN PARTNERS LP

PrivateCIK: 1727492
Location

NEW YORK, NY

πŸ“‹ What this filing means

CALIGAN PARTNERS LP filed this quarterly 13F‑HR report disclosing 17 equity positions with a total reported market value of $763.51M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

17
Positions
$763.51M
Total AUM (reported)
31.13M
Total Shares

Allocation by class

TOTAL AUM$763.51M17 positions
COM$437.34M57.3%
COM NEW$198.92M26.1%
SPONSORED ADS$123.27M16.1%
COM SHS$3.98M0.5%

Portfolio Concentration

Top 354.1%4–1039.2%11–256.7%TOP 1093.3%0%100%
Top 3$413.03M54.1%
4–10$299.60M39.2%
11–25$50.88M6.7%

Top 3 weight

54.1%

Top 10 weight

93.3%

Voting Authority Distribution

Total shares with voting rights: 31.13M

Sole

Full voting authority

31.13M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole17
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings17
Rows:

LIQUIDIA CORPORATION

SOLE
COM NEW
Shares8.12M
TypeSH
Market value$184.62M
24.18%
Sole
8.12M
Shared
0.00
None
0.00

ABIVAX SA

SOLE
SPONSORED ADS
Shares1.45M
TypeSH
Market value$123.27M
16.14%
Sole
1.45M
Shared
0.00
None
0.00

MINERALYS THERAPEUTICS INC

SOLE
COM
Shares2.77M
TypeSH
Market value$105.14M
13.77%
Sole
2.77M
Shared
0.00
None
0.00

AGIOS PHARMACEUTICALS INC

SOLE
COM
Shares2.11M
TypeSH
Market value$84.54M
11.07%
Sole
2.11M
Shared
0.00
None
0.00

EXELIXIS INC

SOLE
COM
Shares1.53M
TypeSH
Market value$63.01M
8.25%
Sole
1.53M
Shared
0.00
None
0.00

REVOLUTION MEDICINES INC

SOLE
COM
Shares1.06M
TypeSH
Market value$49.70M
6.51%
Sole
1.06M
Shared
0.00
None
0.00

ADMA BIOLOGICS INC

SOLE
COM
Shares2.64M
TypeSH
Market value$38.65M
5.06%
Sole
2.64M
Shared
0.00
None
0.00

EVOLUS INC

SOLE
COM
Shares4.14M
TypeSH
Market value$25.41M
3.33%
Sole
4.14M
Shared
0.00
None
0.00

MERUS N V

SOLE
COM
Shares216.95K
TypeSH
Market value$20.43M
2.68%
Sole
216.95K
Shared
0.00
None
0.00

XENON PHARMACEUTICALS INC

SOLE
COM
Shares444.56K
TypeSH
Market value$17.85M
2.34%
Sole
444.56K
Shared
0.00
None
0.00

ANIKA THERAPEUTICS INC

SOLE
COM
Shares1.44M
TypeSH
Market value$13.49M
1.77%
Sole
1.44M
Shared
0.00
None
0.00

AVALO THERAPEUTICS INC

SOLE
COM NEW
Shares833.33K
TypeSH
Market value$10.59M
1.39%
Sole
833.33K
Shared
0.00
None
0.00

TYRA BIOSCIENCES INC

SOLE
COM
Shares696.83K
TypeSH
Market value$9.75M
1.28%
Sole
696.83K
Shared
0.00
None
0.00

INHIBRX BIOSCIENCES INC

SOLE
COM
Shares236.38K
TypeSH
Market value$7.96M
1.04%
Sole
236.38K
Shared
0.00
None
0.00

VERRICA PHARMACEUTICALS INC

SOLE
COM SHS
Shares923.91K
TypeSH
Market value$3.98M
0.52%
Sole
923.91K
Shared
0.00
None
0.00

SELLAS LIFE SCIENCES GROUP I

SOLE
COM NEW
Shares2.30M
TypeSH
Market value$3.70M
0.48%
Sole
2.30M
Shared
0.00
None
0.00

AURA BIOSCIENCES INC

SOLE
COM
Shares227.17K
TypeSH
Market value$1.40M
0.18%
Sole
227.17K
Shared
0.00
None
0.00
CALIGAN PARTNERS LP 13F Holdings β€” 17 Positions | Finecho